Chromosome 17

Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

ENTITIES: by Chromosome band

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Chromosome 17


[previous]   17 17p 17q 17p13 17p12 17p11 17p10 17q10 17q11 17q12 17q21 17q22 17q23 17q24 17q25   [next]

chr17:0-81195210 (81195.21 Kb)

Abnormalities in chromosome 17

(click on headers to reorder columns)
Band 1Band 2ClassEntityPartner 1Partner 2LinksTopographyMorphology[PubMed][Study]
17 Mitelman+17  Mitelman (CGAP)ThyroidAdenoma[PubMed] 
17 Mitelman-17  Mitelman (CGAP) Acute erythroleukemia (FAB type M6)  
17 Mitelman+17  Mitelman (CGAP) Acute erythroleukemia (FAB type M6)  
17 Mitelman-17  Mitelman (CGAP) Acute lymphoblastic leukemia/lymphoblastic lymphoma  
17 Mitelman+17  Mitelman (CGAP) Acute lymphoblastic leukemia/lymphoblastic lymphoma[PubMed] 
17 Mitelman+17  Mitelman (CGAP) Acute lymphoblastic leukemia/lymphoblastic lymphoma[PubMed] 
17 Mitelman-17  Mitelman (CGAP) Acute megakaryoblastic leukemia (FAB type M7)  
17 Mitelman+17  Mitelman (CGAP) Acute megakaryoblastic leukemia (FAB type M7)  
17 Mitelman-17  Mitelman (CGAP) Acute monoblastic leukemia (FAB type M5)  
17 Mitelman+17  Mitelman (CGAP) Acute monoblastic leukemia (FAB type M5)  
17 Mitelman-17  Mitelman (CGAP) Acute monoblastic leukemia without differentiation (FAB type M5a)  
17 Mitelman-17  Mitelman (CGAP) Acute myeloblastic leukemia with maturation (FAB type M2)  
17 Mitelman+17  Mitelman (CGAP) Acute myeloblastic leukemia with maturation (FAB type M2)  
17 Mitelman-17  Mitelman (CGAP) Acute myeloblastic leukemia with minimal differentiation (FAB type M0)  
17 Mitelman+17  Mitelman (CGAP) Acute myeloblastic leukemia with minimal differentiation (FAB type M0)  
17 Mitelman-17  Mitelman (CGAP) Acute myeloblastic leukemia without maturation (FAB type M1)  
17 Mitelman+17  Mitelman (CGAP) Acute myeloblastic leukemia without maturation (FAB type M1)  
17 Mitelman-17  Mitelman (CGAP) Acute myeloid leukemia, NOS[PubMed] 
17 Mitelman-17  Mitelman (CGAP) Acute myeloid leukemia, NOS[PubMed] 
17 Mitelman+17  Mitelman (CGAP) Acute myeloid leukemia, NOS[PubMed] 
17 Mitelman+17  Mitelman (CGAP) Acute myeloid leukemia, NOS[PubMed] 
17 Mitelman-17  Mitelman (CGAP) Acute myelomonocytic leukemia (FAB type M4)  
17 Mitelman+17  Mitelman (CGAP) Acute myelomonocytic leukemia (FAB type M4)  
17 Mitelman-17  Mitelman (CGAP) Acute promyelocytic leukemia (FAB type M3)  
17 Mitelman+17  Mitelman (CGAP) Acute promyelocytic leukemia (FAB type M3)  
17 Mitelman-17  Mitelman (CGAP) Acute undifferentiated leukemia  
17 Mitelman+17  Mitelman (CGAP) Adenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)AdrenalNeuroblastoma  
17 Mitelman+17  Mitelman (CGAP)AdrenalNeuroblastoma  
17 Mitelman-17  Mitelman (CGAP) Adult T-cell lymphoma/leukemia (HTLV-1+)  
17 Mitelman+17  Mitelman (CGAP) Adult T-cell lymphoma/leukemia (HTLV-1+)  
17 Mitelman+17  Mitelman (CGAP) Anaplastic large cell lymphoma, cutaneous type  
17 Mitelman-17  Mitelman (CGAP) Anaplastic large cell lymphoma, systemic type  
17 Mitelman+17  Mitelman (CGAP) Anaplastic large cell lymphoma, systemic type  
17 Mitelman-17  Mitelman (CGAP) Angioimmunoblastic T-cell lymphoma  
17 Mitelman+17  Mitelman (CGAP) Angioimmunoblastic T-cell lymphoma  
17 Mitelman-17  Mitelman (CGAP)AnusSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP) B-cell lymphoma associated with hemophagocytic syndrome  
17 Mitelman-17  Mitelman (CGAP) Bilineage or biphenotypic leukemia  
17 Mitelman+17  Mitelman (CGAP) Bilineage or biphenotypic leukemia  
17 Mitelman-17  Mitelman (CGAP)BladderTransitional cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)BladderTransitional cell carcinoma  
17 Mitelman-17  Mitelman (CGAP) B-prolymphocytic leukemia  
17 Mitelman-17  Mitelman (CGAP)BrainAstrocytoma, grade I-II  
17 Mitelman-17  Mitelman (CGAP)BrainAstrocytoma, grade III-IV/Glioblastoma  
17 Mitelman+17  Mitelman (CGAP)BrainAstrocytoma, grade III-IV/Glioblastoma  
17 Mitelman-17  Mitelman (CGAP)BrainAstrocytoma, NOS  
17 Mitelman+17  Mitelman (CGAP)BrainAstrocytoma, NOS  
17 Mitelman+17  Mitelman (CGAP)BrainAstrocytoma, pilocytic/juvenile  
17 Mitelman-17  Mitelman (CGAP)BrainChoroid plexus papilloma/carcinoma  
17 Mitelman+17  Mitelman (CGAP)BrainChoroid plexus papilloma/carcinoma  
17 Mitelman-17  Mitelman (CGAP)BrainEpendymoma  
17 Mitelman+17  Mitelman (CGAP)BrainEpendymoma  
17 Mitelman+17  Mitelman (CGAP)BrainGlioma, NOS  
17 Mitelman-17  Mitelman (CGAP)BrainMeningioma  
17 Mitelman+17  Mitelman (CGAP)BrainMeningioma[PubMed] 
17 Mitelman+17  Mitelman (CGAP)BrainMeningioma[PubMed] 
17 Mitelman-17  Mitelman (CGAP)BrainNeuroglial neoplasm, special type  
17 Mitelman-17  Mitelman (CGAP)BrainOligodendroglioma  
17 Mitelman-17  Mitelman (CGAP)BrainPrimitive neuroectodermal tumor/Medulloblastoma  
17 Mitelman-17  Mitelman (CGAP)BrainSchwannoma  
17 Mitelman-17  Mitelman (CGAP)Brain stemAstrocytoma, grade III-IV/Glioblastoma  
17 Mitelman-17  Mitelman (CGAP)BreastAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)BreastAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)BreastBenign epithelial tumor, NOS  
17 Mitelman+17  Mitelman (CGAP)BreastBenign epithelial tumor, NOS  
17 Mitelman-17  Mitelman (CGAP)BreastBenign epithelial tumor, special type  
17 Mitelman+17  Mitelman (CGAP)BreastBenign epithelial tumor, special type  
17 Mitelman-17  Mitelman (CGAP)BreastCarcinoma in situ  
17 Mitelman-17  Mitelman (CGAP)BreastCarcinoma, NOS  
17 Mitelman+17  Mitelman (CGAP)BreastCarcinoma, NOS  
17 Mitelman-17  Mitelman (CGAP)BreastHyperplasia  
17 Mitelman-17  Mitelman (CGAP)BreastMalignant epithelial tumor, special type  
17 Mitelman-17  Mitelman (CGAP)BreastPhyllodes tumor, malignant  
17 Mitelman-17  Mitelman (CGAP) Burkitt lymphoma/leukemia  
17 Mitelman+17  Mitelman (CGAP) Burkitt lymphoma/leukemia  
17 Mitelman-17  Mitelman (CGAP)CerebellumEpendymoma  
17 Mitelman+17  Mitelman (CGAP)CerebellumMeningioma  
17 Mitelman-17  Mitelman (CGAP)CerebellumPrimitive neuroectodermal tumor/Medulloblastoma  
17 Mitelman+17  Mitelman (CGAP)CerebellumPrimitive neuroectodermal tumor/Medulloblastoma  
17 Mitelman-17  Mitelman (CGAP) Chronic lymphocytic leukemia  
17 Mitelman+17  Mitelman (CGAP) Chronic lymphocytic leukemia  
17 Mitelman-17  Mitelman (CGAP) Chronic myeloid leukemia, aberrant translocation  
17 Mitelman+17  Mitelman (CGAP) Chronic myeloid leukemia, aberrant translocation  
17 Mitelman-17  Mitelman (CGAP) Chronic myeloid leukemia, t(9;22)  
17 Mitelman+17  Mitelman (CGAP) Chronic myeloid leukemia, t(9;22)  
17 Mitelman+17  Mitelman (CGAP) Chronic myeloid leukemia, t(9;22)  
17 Mitelman-17  Mitelman (CGAP) Chronic myelomonocytic leukemia  
17 Mitelman-17  Mitelman (CGAP) Chronic myeloproliferative disorder, NOS  
17 Mitelman-17  Mitelman (CGAP) Dendritic cell neoplasm  
17 Mitelman-17  Mitelman (CGAP) Diffuse large B-cell lymphoma  
17 Mitelman+17  Mitelman (CGAP) Diffuse large B-cell lymphoma  
17 Mitelman-17  Mitelman (CGAP) Essential thrombocythemia  
17 Mitelman-17  Mitelman (CGAP) Extranodal NK/T-cell lymphoma  
17 Mitelman-17  Mitelman (CGAP)EyeMalignant melanoma  
17 Mitelman+17  Mitelman (CGAP)EyeMalignant melanoma  
17 Mitelman-17  Mitelman (CGAP)EyeRetinoblastoma  
17 Mitelman-17  Mitelman (CGAP) Follicular lymphoma  
17 Mitelman+17  Mitelman (CGAP) Follicular lymphoma  
17 Mitelman-17  Mitelman (CGAP)Gallbladder/Biliary systemAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)Gallbladder/Biliary systemAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP) Hairy cell leukemia  
17 Mitelman-17  Mitelman (CGAP) Hodgkin disease, lymphocyte depletion  
17 Mitelman-17  Mitelman (CGAP) Hodgkin disease, lymphocyte predominance  
17 Mitelman-17  Mitelman (CGAP) Hodgkin disease, mixed cellularity  
17 Mitelman+17  Mitelman (CGAP) Hodgkin disease, mixed cellularity  
17 Mitelman-17  Mitelman (CGAP) Hodgkin disease, nodular sclerosis  
17 Mitelman+17  Mitelman (CGAP) Hodgkin disease, nodular sclerosis  
17 Mitelman-17  Mitelman (CGAP) Hodgkin disease, NOS  
17 Mitelman-17  Mitelman (CGAP) Idiopathic myelofibrosis  
17 Mitelman+17  Mitelman (CGAP) Idiopathic myelofibrosis  
17 Mitelman-17  Mitelman (CGAP)IntraabdominalLeiomyosarcoma  
17 Mitelman-17  Mitelman (CGAP)IntraabdominalLiposarcoma, dedifferentiated  
17 Mitelman-17  Mitelman (CGAP)IntraabdominalLiposarcoma, pleomorphic  
17 Mitelman-17  Mitelman (CGAP)IntraabdominalMalignant peripheral nerve sheath tumor/Triton  
17 Mitelman+17  Mitelman (CGAP)IntraabdominalNeuroblastoma  
17 Mitelman+17  Mitelman (CGAP)IntrathoracalCombined germ cell tumors  
17 Mitelman-17  Mitelman (CGAP)IntrathoracalMalignant peripheral nerve sheath tumor/Triton  
17 Mitelman-17  Mitelman (CGAP)KidneyAdenocarcinoma[PubMed] 
17 Mitelman-17  Mitelman (CGAP)KidneyAdenocarcinoma[PubMed] 
17 Mitelman+17  Mitelman (CGAP)KidneyAdenocarcinoma[PubMed] 
17 Mitelman+17  Mitelman (CGAP)KidneyAdenocarcinoma[PubMed] 
17 Mitelman+17  Mitelman (CGAP)KidneyAdenoma  
17 Mitelman-17  Mitelman (CGAP)KidneyBenign epithelial tumor, special type  
17 Mitelman+17  Mitelman (CGAP)KidneyBenign epithelial tumor, special type  
17 Mitelman+17  Mitelman (CGAP)KidneyMalignant epithelial tumor, special type  
17 Mitelman-17  Mitelman (CGAP)KidneyMesoblastic nephroma  
17 Mitelman+17  Mitelman (CGAP)KidneyMesoblastic nephroma  
17 Mitelman-17  Mitelman (CGAP)KidneyOncocytoma  
17 Mitelman-17  Mitelman (CGAP)KidneyWilms tumor  
17 Mitelman+17  Mitelman (CGAP)KidneyWilms tumor  
17 Mitelman-17  Mitelman (CGAP)Large intestineAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)Large intestineAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)Large intestineAdenoma  
17 Mitelman+17  Mitelman (CGAP)Large intestineAdenoma  
17 Mitelman-17  Mitelman (CGAP)Large intestineCarcinoma, NOS  
17 Mitelman+17  Mitelman (CGAP)Large intestineCarcinoma, NOS  
17 Mitelman-17  Mitelman (CGAP)LarynxSquamous cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)LarynxSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP)LiverAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)LiverAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)LiverHepatoblastoma  
17 Mitelman+17  Mitelman (CGAP)LiverHepatoblastoma  
17 Mitelman-17  Mitelman (CGAP)LungAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)LungAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)LungAdenosquamous carcinoma  
17 Mitelman-17  Mitelman (CGAP)LungMalignant epithelial tumor, special type  
17 Mitelman-17  Mitelman (CGAP)LungMesenchymal tumor, special type  
17 Mitelman-17  Mitelman (CGAP)LungSquamous cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)LungSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP)LungUndifferentiated carcinoma  
17 Mitelman+17  Mitelman (CGAP)LungUndifferentiated carcinoma  
17 Mitelman-17  Mitelman (CGAP)LungUndifferentiated carcinoma, large cell  
17 Mitelman-17  Mitelman (CGAP)LungUndifferentiated carcinoma, small cell  
17 Mitelman+17  Mitelman (CGAP)LungUndifferentiated carcinoma, small cell  
17 Mitelman-17  Mitelman (CGAP) Lymphoplasmacytic lymphoma  
17 Mitelman-17  Mitelman (CGAP) Mantle cell lymphoma  
17 Mitelman+17  Mitelman (CGAP) Mantle cell lymphoma  
17 Mitelman-17  Mitelman (CGAP) Mature B-cell neoplasm, NOS[PubMed] 
17 Mitelman-17  Mitelman (CGAP) Mature B-cell neoplasm, NOS[PubMed] 
17 Mitelman+17  Mitelman (CGAP) Mature B-cell neoplasm, NOS[PubMed] 
17 Mitelman+17  Mitelman (CGAP) Mature B-cell neoplasm, NOS[PubMed] 
17 Mitelman-17  Mitelman (CGAP) Mature T- and NK-cell neoplasm, NOS  
17 Mitelman+17  Mitelman (CGAP) Mature T- and NK-cell neoplasm, NOS  
17 Mitelman-17  Mitelman (CGAP) Multiple myeloma  
17 Mitelman+17  Mitelman (CGAP) Multiple myeloma  
17 Mitelman-17  Mitelman (CGAP) Mycosis fungoides/Sézary syndrome  
17 Mitelman+17  Mitelman (CGAP) Mycosis fungoides/Sézary syndrome  
17 Mitelman-17  Mitelman (CGAP) Myelodysplastic syndrome, NOS  
17 Mitelman+17  Mitelman (CGAP) Myelodysplastic syndrome, NOS  
17 Mitelman-17  Mitelman (CGAP)Nasal cavity/Paranasal sinusesSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP)NasopharynxSquamous cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)NasopharynxSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP)OesophagusAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)OesophagusSquamous cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)OesophagusSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP)Oral cavitySquamous cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)Oral cavitySquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP)Oro- and hypopharynxSquamous cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)Oro- and hypopharynxSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP)OvaryAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)OvaryAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)OvaryAdenoma  
17 Mitelman+17  Mitelman (CGAP)OvaryAdenoma  
17 Mitelman-17  Mitelman (CGAP)OvaryCarcinoma, NOS  
17 Mitelman+17  Mitelman (CGAP)OvaryCarcinoma, NOS  
17 Mitelman+17  Mitelman (CGAP)OvaryCombined germ cell tumors  
17 Mitelman-17  Mitelman (CGAP)OvaryMalignant epithelial tumor, special type  
17 Mitelman-17  Mitelman (CGAP)OvaryMetaplastic carcinoma  
17 Mitelman-17  Mitelman (CGAP)OvaryUndifferentiated carcinoma  
17 Mitelman-17  Mitelman (CGAP)PancreasAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)PancreasAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)PancreasCarcinoid tumor  
17 Mitelman-17  Mitelman (CGAP)PancreasCarcinoma, NOS  
17 Mitelman-17  Mitelman (CGAP) Peripheral T-cell lymphoma, unspecified  
17 Mitelman+17  Mitelman (CGAP) Peripheral T-cell lymphoma, unspecified  
17 Mitelman-17  Mitelman (CGAP)PituitaryAdenoma  
17 Mitelman+17  Mitelman (CGAP)PituitaryAdenoma  
17 Mitelman-17  Mitelman (CGAP) Plasma cell leukemia  
17 Mitelman+17  Mitelman (CGAP) Plasma cell leukemia  
17 Mitelman-17  Mitelman (CGAP)PleuraMesothelioma  
17 Mitelman+17  Mitelman (CGAP)PleuraMesothelioma  
17 Mitelman-17  Mitelman (CGAP) Polycythemia vera  
17 Mitelman-17  Mitelman (CGAP)ProstateAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP) Refractory anemia  
17 Mitelman-17  Mitelman (CGAP) Refractory anemia with excess blasts-1  
17 Mitelman-17  Mitelman (CGAP) Refractory anemia with excess blasts-2  
17 Mitelman-17  Mitelman (CGAP) Refractory anemia with excess of blasts (FAB)  
17 Mitelman+17  Mitelman (CGAP) Refractory anemia with excess of blasts (FAB)  
17 Mitelman-17  Mitelman (CGAP) Refractory anemia with ringed sideroblasts  
17 Mitelman-17  Mitelman (CGAP) Refractory cytopenia with multilineage dysplasia  
17 Mitelman-17  Mitelman (CGAP)Salivary glandMalignant epithelial tumor, special type  
17 Mitelman-17  Mitelman (CGAP)SkeletonChondroma  
17 Mitelman-17  Mitelman (CGAP)SkeletonChondrosarcoma, clear cell  
17 Mitelman-17  Mitelman (CGAP)SkeletonChondrosarcoma, dedifferentiated  
17 Mitelman+17  Mitelman (CGAP)SkeletonChondrosarcoma, dedifferentiated  
17 Mitelman-17  Mitelman (CGAP)SkeletonChondrosarcoma, NOS  
17 Mitelman+17  Mitelman (CGAP)SkeletonChondrosarcoma, NOS  
17 Mitelman-17  Mitelman (CGAP)SkeletonChordoma  
17 Mitelman-17  Mitelman (CGAP)SkeletonEwing sarcoma  
17 Mitelman+17  Mitelman (CGAP)SkeletonEwing sarcoma  
17 Mitelman-17  Mitelman (CGAP)SkeletonOsteosarcoma, NOS  
17 Mitelman+17  Mitelman (CGAP)SkeletonOsteosarcoma, NOS  
17 Mitelman-17  Mitelman (CGAP)SkeletonOsteosarcoma, telangiectatic  
17 Mitelman-17  Mitelman (CGAP)SkinMalignant melanoma  
17 Mitelman+17  Mitelman (CGAP)SkinMalignant melanoma  
17 Mitelman-17  Mitelman (CGAP)SkinMerkel cell carcinoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueAlveolar rhabdomyosarcoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueAlveolar rhabdomyosarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueAlveolar soft part sarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueAtypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueClear cell sarcoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueClear cell sarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueEmbryonal rhabdomyosarcoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueEmbryonal rhabdomyosarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueEpithelioid sarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueEwing sarcoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueEwing sarcoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueFibrosarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueInflammatory myofibroblastic tumor/myofibroblastic sarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueLeiomyosarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueLipoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueLiposarcoma, myxoid/round cell  
17 Mitelman-17  Mitelman (CGAP)Soft tissueLiposarcoma, pleomorphic  
17 Mitelman-17  Mitelman (CGAP)Soft tissueMalignant peripheral nerve sheath tumor/Triton  
17 Mitelman+17  Mitelman (CGAP)Soft tissueMalignant peripheral nerve sheath tumor/Triton  
17 Mitelman-17  Mitelman (CGAP)Soft tissueMyoepithelioma/myoepithelial carcinoma/mixed tumor  
17 Mitelman-17  Mitelman (CGAP)Soft tissueMyxofibrosarcoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueMyxofibrosarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueMyxoinflammatory fibroblastic sarcoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueNeuroblastoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueNonneoplastic mesenchymal disorder/lesion  
17 Mitelman-17  Mitelman (CGAP)Soft tissuePleomorphic rhabdomyosarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueRhabdomyosarcoma, NOS  
17 Mitelman+17  Mitelman (CGAP)Soft tissueSchwannoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueSclerosing epithelioid fibrosarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueSolitary fibrous tumor  
17 Mitelman-17  Mitelman (CGAP)Soft tissueSpindle cell/pleomorphic lipoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueSynovial sarcoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueSynovial sarcoma  
17 Mitelman-17  Mitelman (CGAP)Soft tissueUndifferentiated pleomorphic sarcoma  
17 Mitelman+17  Mitelman (CGAP)Soft tissueUndifferentiated pleomorphic sarcoma  
17 Mitelman-17  Mitelman (CGAP)Spinal cordSchwannoma  
17 Mitelman-17  Mitelman (CGAP) Splenic marginal zone B-cell lymphoma  
17 Mitelman-17  Mitelman (CGAP) Squamous cell carcinoma[PubMed] 
17 Mitelman-17  Mitelman (CGAP)StomachAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)StomachAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)StomachGastrointestinal stromal tumor  
17 Mitelman+17  Mitelman (CGAP)StomachGastrointestinal stromal tumor  
17 Mitelman-17  Mitelman (CGAP)TestisCombined germ cell tumors  
17 Mitelman+17  Mitelman (CGAP)TestisCombined germ cell tumors  
17 Mitelman-17  Mitelman (CGAP)TestisDiffuse large B-cell lymphoma  
17 Mitelman-17  Mitelman (CGAP)TestisSeminoma/Dysgerminoma  
17 Mitelman+17  Mitelman (CGAP)TestisSeminoma/Dysgerminoma  
17 Mitelman-17  Mitelman (CGAP)TestisTeratoma (mature and immature)  
17 Mitelman+17  Mitelman (CGAP)TestisTeratoma (mature and immature)  
17 Mitelman-17  Mitelman (CGAP)ThyroidAdenocarcinoma  
17 Mitelman+17  Mitelman (CGAP)ThyroidAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)ThyroidAdenoma  
17 Mitelman+17  Mitelman (CGAP)ThyroidAdenoma[PubMed] 
17 Mitelman+17  Mitelman (CGAP)ThyroidNonneoplastic epithelial disorder/lesion  
17 Mitelman-17  Mitelman (CGAP)ThyroidUndifferentiated carcinoma  
17 Mitelman-17  Mitelman (CGAP)TongueSquamous cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)TongueSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP) T-prolymphocytic leukemia  
17 Mitelman-17  Mitelman (CGAP)Unknown siteMalignant melanoma  
17 Mitelman+17  Mitelman (CGAP)Unknown siteMalignant melanoma  
17 Mitelman+17  Mitelman (CGAP)Unknown siteNeuroblastoma  
17 Mitelman-17  Mitelman (CGAP)Uterus, cervixAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)Uterus, cervixSquamous cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)Uterus, cervixSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP)Uterus, corpusAdenocarcinoma  
17 Mitelman-17  Mitelman (CGAP)Uterus, corpusLeiomyoma  
17 Mitelman-17  Mitelman (CGAP)Uterus, corpusLeiomyosarcoma  
17 Mitelman-17  Mitelman (CGAP)Uterus, corpusMetaplastic carcinoma  
17 Mitelman-17  Mitelman (CGAP)VaginaSquamous cell carcinoma  
17 Mitelman+17  Mitelman (CGAP)VaginaSquamous cell carcinoma  
17 Mitelman-17  Mitelman (CGAP) Waldenström macroglobulinemia  
17 dbCRIDdel(17)(center q11.2)  11188Von Recklinghausen Neurofibromatosis[PubMed] 
17 Mitelmander(17)  Mitelman (CGAP) Acute lymphoblastic leukemia/lymphoblastic lymphoma[PubMed] 
17 Mitelmander(17)  Mitelman (CGAP) Burkitt lymphoma/leukemia[PubMed] 
17 Mitelmander(17)  Mitelman (CGAP) Chronic myeloid leukemia, t(9;22)[PubMed] 
17 Mitelmander(17)  Mitelman (CGAP) Follicular lymphoma[PubMed] 
17 Mitelmander(17)  Mitelman (CGAP) Mature B-cell neoplasm, NOS[PubMed] 
17p13 Mitelmander(17)(p13)  Mitelman (CGAP) Chronic lymphocytic leukemia[PubMed] 
  Mitelmander(17)(p?)  Mitelman (CGAP) Acute lymphoblastic leukemia/lymphoblastic lymphoma[PubMed] 
  Mitelmander(17)(p?)  Mitelman (CGAP) Acute myeloid leukemia, NOS[PubMed] 
  Mitelmander(17)(p?)  Mitelman (CGAP)BrainAstrocytoma, grade III-IV/Glioblastoma[PubMed] 
  Mitelmander(17)(p?)  Mitelman (CGAP) Chronic lymphocytic leukemia[PubMed] 
  Mitelmander(17)(p?)  Mitelman (CGAP) Follicular lymphoma[PubMed] 
  Mitelmander(17)(p?)  Mitelman (CGAP) Mature B-cell neoplasm, NOS[PubMed] 
  Mitelmander(17)(p?)  Mitelman (CGAP) Myelodysplastic syndrome, NOS[PubMed] 
  Mitelmander(17)(q?)  Mitelman (CGAP) Acute myeloid leukemia, NOS[PubMed] 
  Mitelmander(17)(q?)  Mitelman (CGAP)AdrenalNeuroblastoma[PubMed] 
  Mitelmander(17)(q?)  Mitelman (CGAP)BrainAstrocytoma, grade III-IV/Glioblastoma[PubMed] 
  Mitelmander(17)(q?)  Mitelman (CGAP) Chronic lymphocytic leukemia[PubMed] 
17 Mitelmandup(17)(p?)  Mitelman (CGAP)KidneyAdenocarcinoma[PubMed] 
17 Mitelmandup(17)(q?)  Mitelman (CGAP)KidneyAdenocarcinoma[PubMed] 
[ Bold normal : A; Italic normal :G; Italic small : E ]

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
[previous]   17 17p 17q 17p13 17p12 17p11 17p10 17q10 17q11 17q12 17q21 17q22 17q23 17q24 17q25   [next]

References

Contributor(s)

Writtenmay 2012Philippe Dessen
  
Updatedfévr. 2017Philippe Dessen and Jean-Loup Huret

Citation

This paper should be referenced as such :
Dessen P and Huret JL. Chromosomal band 17. Atlas Genet Cytogenet Oncol Haematol. July 2012.
URL : http://atlasgeneticsoncology.org/Bands/17.html
© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : mar. févr. 14 12:34:00 CET 2017


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case reports   Journals   Portal   Teaching